Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Antibody-Mediated Autoimmune Encephalitis in Childhood.
Effectiveness of intramuscular injections of botulinum toxin in the treatment of disabling cerebellar tremor of the hand.
Why use sex hormones in relapsing-remitting multiple sclerosis? - Authors' reply.
The Brain Proteome of the Ubiquitin Ligase Peli1 Knock-Out Mouse during Experimental Autoimmune Encephalomyelitis.
Regarding the past, what is the trial you have always been dreaming of in CIDP?
Safety of monoclonal antibodies for the treatment of multiple sclerosis.
[Appraisal of the formation of afterimages by means of a new computer application in patients with demyelinating optic neuropathies].
The patient's perspective: How to create awareness for improving access to care and treatment of MS patients?
A Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future Perspectives.
Treatment patterns and health care resource utilization associated with dalfampridine extended release in multiple sclerosis: a retrospective claims database analysis.
Description of the Characteristics of Multiple Sclerosis Patients in the Region of Valencia (Spain) Who Requested Treatment with Disease-Modifying Drugs during the 2005-2014 Decade.
Long-term real life efficacy of onabotulinum toxin A for the treatment of neurogenic detrusor overactivity in a population using intermittent self-catheterization.
Urban traffic-derived nanoparticulate matter reduces neurite outgrowth via TNFα in vitro.
The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography.
Contribution of EAE to understanding and treating multiple sclerosis.
Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging.
Fatigue and depression in multiple sclerosis: pharmacological and non-pharmacological interventions.
Effect of melatonin supplementation on plasma lipid hydroperoxides, homocysteine concentration and chronic fatigue syndrome in multiple sclerosis patients treated with interferons-beta and mitoxantrone.
Pathophysiological Concepts in Multiple Sclerosis and the Therapeutic Effects of Hydrogen Sulfide.
Corrigendum.
Multiple Sclerosis.
Findings of Optical Coherence Tomography of Retinal Nerve Fiber Layer in Two Common Types of Multiple Sclerosis.
Hyponatremia in patients with liver diseases: not just a cirrhosis-induced hemodynamic compromise.
The payer's perspective: What is the burden of MS and how should the patient's perspective be integrated in health technology assessment conducted for taking decisions on access to care and treatment?
IL4I1 augments CNS remyelination and axonal protection by modulating T cell driven inflammation.
Pages
« first
‹ previous
…
792
793
794
795
796
797
798
799
800
…
next ›
last »